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Methodology Ultrasensitive quantitation of human 
papillomavirus type 16 E6 oncogene sequences by 
nested real time PCR
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Abstract
Background: We have developed an ultrasensitive method based on conventional PCR preamplification followed by 
nested amplification through real time PCR (qPCR) in the presence of the DNA intercalating agent EvaGreen.
Results: Amplification mixtures calibrated with a known number of pHV101 copies carrying a 645 base pair (bp)-long 
insert of the human papillomavirus type 16 (HPV16) E6 oncogene were used to generate the E6-1 amplicon of 645 bp 
by conventional PCR and then the E6-2 amplicon of 237 bp by nested qPCR. Direct and nested qPCR mixtures for E6-2 
amplification corresponding to 2.5 × 102-2.5 × 106 initial pHV101 copies had threshold cycle (Ct) values in the ranges of 
18.7-29.0 and 10.0-25.0, respectively. The Ct of qPCR mixtures prepared with 1/50 volumes of preamplified mixtures 
containing 50 ng of DNA of the SiHa cell line (derived from an invasive cervical cancer with one HPV16 genome per 
cell) was 19.9. Thermal fluorescence extinction profiles of E6-2 amplicons generated from pHV101 and SiHa DNA were 
identical, with a peak at 85.5°C.
Conclusions: Our method based on conventional preamplification for 15 cycles increased 10,750 times the sensitivity 
of nested qPCR for the quantitation of the E6 viral oncogene and confirmed that the SiHa cell line contains one E6-
HPV16 copy per cell.
Background
Invasive cervical cancer develops in women with persis-
tent infection by high-risk human papillomavirus (HR-
HPV), among which HPV16 and HPV18 are the most fre-
quent types [1], HPV16 being the most prevalent and
associated with nearly half of the invasive cervical cancer
cases in the world [2,3].
Molecular methods to quantify the number of HPV16
genome copies serve to determine the viral load and the
progression of HPV16 neoplastic lesions. Hybrid capture
[4] or "nested" PCR [5] are used for molecular diagnosis
of HPV infection, whereas qPCR is used to assess viral
load and integration to the cellular genome [6,7].
Conventional nested PCR is more sensitive than con-
ventional "direct" PCR to detect HPV16 E6 oncogene
sequences [8,9] whose quantitation is reproducible, spe-
cific and more sensitive in qPCR mixtures containing the
DNA intercalating agent EvaGreen [10].
In this work we developed an ultrasensitive method to
quantify E6-HPV16 oncogene sequences in two steps: 1)
preamplification of the E6-1 (645 bp) sequence through
15 cycles of direct conventional PCR, and 2) amplifica-
tion of the E6-2 (237 bp) sequence through nested qPCR
in the presence of EvaGreen. Preamplification signifi-
cantly increased the sensitivity and the method con-
firmed that the SiHa cell line contains only one copy of
the HPV16 genome per cell.
Results
E6-2 amplification by direct qPCR
E6-2 amplification from pHV101 in direct qPCR mix-
tures containing the pU1M/pU2R primer pair and 2.5 ×
102  to 2.5 × 106  pHV101 copies in the presence of
EvaGreen yielded a consistent family of type curves with
Ct values between 18.70 and 29.00, ΔCt values in the 3.1-
3.8 range, and lack of fluorescence increase in mixtures
devoid of DNA. These experiments indicated that at least
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2,500 copies of the E6 oncogene can be quantified by
direct qPCR (Fig. 1A).
Preamplification and nested qPCR
To increase qPCR sensitivity E6-1 was first "preamplified"
in conventional PCR mixtures and E6-2 was then "ampli-
fied" in nested qPCR mixtures containing EvaGreen, the
LCRS/E7AS primer pair, and 1/50 volume of the corre-
sponding preamplified mixtures.
T he families of type curves r equir ed t o calibra t e the
number of E6 copies and to quantify them in problem
samples could be generated from nested qPCR mixtures
derived from two types of preamplification mixtures: a)
"complete" mixtures, prepared with serial logarithmic
dilutions of the pHV101 template molecules before pre-
amplification, and b) "minimum" mixtures, prepared with
serial logarithmic dilutions from a single preamplified
mixture containing the maximum number of template
molecules used in complete mixtures.
Since labor, time and the amount of reagents are signif-
icantly reduced using minimum mixtures, we compared
the results from nested qPCR mixtures prepared with 1/
50 volume samples from preamplified mixtures which
contained pHV101 molecules in the range of 2.5 × 102-to
2.5 × 106 copies with those prepared using serial logarith-
mic dilutions from a single mixture containing 2.5 × 106
pHV101 molecules that had been preamplified. We also
added 50 ng of "carrier" normal human blood DNA to
both complete and minimum positive preamplification
mixtures (same amount as SiHa DNA in problem mix-
tures) and found that all of them generate equivalent
nested qPCR amplification results.
Typical Ct values of nested qPCR: 10.80 for 2.5 × 106,
14.35 for 2.5 × 105, 17.71 for 2.5 × 104, 21.62 for 2.5 × 103
and 25.02 for 2.5 × 102 initial pHV101 copies in the pre-
a m p l i f i c a t i o n  m i x t u r e s  ( T a b l e  1 )  w e r e  c o n s i s t e n t  ( Δ C t
range: 3.3-3.9) and reproducible (R2 = 1.000), whereas the
negative control mixture devoid of template DNA had a
Ct = 27 (Fig. 1B).
Figure 1 Family of E6-2 amplification curves obtained by direct and nested qPCR. RFU, relative fluorescence units. Threshold (thick horizontal 
line): 50 RFU. (A) Family of curves obtained in direct qPCR mixtures with pHV101 dilutions and primers for E6-2. Curve 1, 2.5 × 106 pHV101 copies. Curve 
2, 2.5 × 105 copies. Curve 3, 2.5 × 104 copies. Curve 4, 2.5 × 103 copies. Curve 5, Blank (without DNA). (B) Family of curves obtained by nested qPCR with 
E6-2 primers and 1/50 volume of mixtures preamplified 15 cycles with pHV101 and E6-1 primers. Curve 1, 2.5 × 106 pHV101 copies. Curve 2, 2.5 × 105 
copies. Curve 3, 2.5 × 104 copies. Curve 4, 2.5 × 103 copies. Curve 5, 2.5 × 102 copies. Curve 6, blank (without DNA).Hernández-Arteaga and López-Revilla Infectious Agents and Cancer 2010, 5:9
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The average decrease in Ct values of nested qPCR
resulting from preamplification for 15 cycles was 7.78
(Table 1), corresponding to a 215-fold sensitivity increase.
Multiplying this factor by the 50-fold dilution factor of
preamplified samples in nested reactions implies that
under the conditions used the overall sensitivity of nested
qPCR increased 10,750 times.
E6 copies per SiHa cell
The sensitivity and reliability of the nested qPCR method
was tested by determining the HPV16 genome load
through quantitation of E6 sequences present in the SiHa
line, known to contain only one copy of the HPV16
genome per cell [11].
The following PCR mixtures containing the LCRS/
E7AS primer pair and the DNA templates indicated were
incubated for 15 cycles under conditions to generate
("preamplify") the E6-1 amplicon: a) positive controls
with 2.5 × 106-2.5 × 102 copies of pHV101 and 50 ng of
"carrier" normal human blood DNA; b) negative controls
with 50 ng of "carrier" DNA; c) problem samples with 50
ng of SiHa DNA; and d) blanks, without DNA. Nested
qPCR mixtures containing EvaGreen, the pU1M/pU2R
primer pair and 1/50 volume from each preamplified
mixture were incubated for 35 cycles.
In nested qPCR mixtures for E6-2 containing 1/50 vol-
umes of serial logarithmic dilutions from preamplified
mixtures with 2.5 × 106 to 2.5 × 102 pHV101 molecules
the Ct values ranged from 10.8 to 25.0 cycles (R2 = 1.000;
slope = -3.57), and the ΔCt values were consistent (range:
3.3-3.9). The Ct values of nested qPCR mixtures prepared
without preamplified samples were 27.0 and 28.0,
whereas the basal fluorescence decreased slightly in pre-
amplification mixtures containing SiHa DNA with the
pU1M primer only (Fig. 2A).
The family of type curves obtained from nested qPCR
mixtures for E6-2 amplification was consistent with the
initial pHV101 copy number. On the other hand, the Ct
value (19.9) and E6 copy number obtained from a typical
preamplification mixture containing 50 ng of SiHa cell
DNA (equivalent to 6.05 × 103 HPV16 genome copies)
had the magnitudes expected (i.e., one E6 copy per 7.1 pg
of DNA, equivalent to the genomic mass of a human dip-
loid cell) (Fig. 2A).
The thermal denaturation ("fluorescence extinction")
profiles of nested qPCR products generated from
pHV101 and SiHa DNA were identical, with a major peak
around 85.5°C whose magnitude was proportional to the
initial number of pHV101 copies, and clearly different
from the secondary peak at 78.5°C which appeared in the
negative controls containing just the forward primer of
the second pair (Fig. 2B).
Discussion
Our group has already confirmed that detection of HPV
infection is more sensitive by nested conventional PCR
through the successive synthesis of the E6-1 and E6-2
amplicons used in this work [9], and that quantitation of
E 6  o n c o g e n e  s e q u e n c e s  b y  q P C R  i n  t h e  p r e s e n c e  o f
EvaGreen is reproducible and specific [10].
The PCR mixtures required to calibrate and quantify
the number of E6 copies present in problem samples were
prepared using serial logarithmic dilutions of pHV101, a
pGEM construct containing a 645 bp-insert whose
sequence corresponds to the E6-HPV16 ORF [10].
To increase amplification sensitivity, E6-1 was "pream-
plified" for 15 conventional PCR cycles and then E6-2 was
"amplified" by 35 "nested" qPCR cycles in the presence of
normal human DNA using, as source of template, 1/50
volume of either preamplified mixtures prepared with
serial logarithmic dilutions of pHV101 or with serial log-
arithmic dilutions of a single preamplified mixture pre-
pared with the highest number of pHV101 copies. Direct
Table 1: Ct values in direct and nested qPCR E6-2 amplicon mixtures with a variable number of pHV101 copies
pHV101 copies Ct ΔCt
Direct qPCR Nested qPCR
2.5 × 102 --- 25.02 ---
2.5 × 103 29.00 21.62 7.40
2.5 × 104 25.90 17.71 8.10
2.5 × 105 22.10 14.35 7.75
2.5 × 106 18.70 10.80 7.90Hernández-Arteaga and López-Revilla Infectious Agents and Cancer 2010, 5:9
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PCR could quantify as little as 2,500 E6-HPV16 mole-
cules, whereas nested qPCR was around 11,000 times
more sensitive, a value close to that expected for 15 pre-
amplification cycles which would increase the initial
number of E6 template copies by a factor of 213 = 8,192.
Non-specific fluorescence appears to depend on the
interaction of the two E6-2 primers because it increased
after cycle 27 in qPCR mixtures prepared with samples
from preamplified mixtures containing normal human
DNA or HPV16 DNA, but not from those containing
SiHa DNA and the E6-2 forward primer only.
Use of the SiHa cell line, originally isolated from an
invasive cervical cancer caused by HPV16 and known to
contain only one viral genome per cell [11], confirmed
Figure 2 Thermal denaturation (fluorescence extinction) profiles of the E6-2 amplicons generated from pHV101 and SiHa DNA. RFU, relative 
fluorescence units. (A) Family of curves obtained with serially diluted pHV101 or 50 ng of SiHa DNA. Threshold (thick horizontal line): 50 RFU. Curve 1, 
2.5 × 106 pHV101 copies. Curve 2, 2.5 × 105 pHV101 copies. Curve 3, 2.5 × 104 pHV101 copies. Curve 4, 2.5 × 103 pHV101 copies. Curve 5, 2.5 × 
102pHV101 copies. Curve 6, Blank (without DNA). Curve 7, normal human blood DNA. Curve 8, 50 ng of SiHa cell DNA with the pU1M/pU1R primer 
pair. Curve 9, 50 ng of SiHa cell DNA with the pU1M forward primer only. (B) Thermal fluorescence extinction profiles of nested qPCR products. Profiles 
of pHV101 and SiHa DNA mixtures with both primers (peaks at 85.5°C), mixtures without DNA or with normal human blood DNA with both primers 
(peaks at 78.5°C), and SiHa DNA with the pU1M primer only (nearly horizontal line close to the baseline).Hernández-Arteaga and López-Revilla Infectious Agents and Cancer 2010, 5:9
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Figure 3 Sequences of the E6-1 and E6-2 amplicons generated from pHV101. (A) Diagram of the HPV16 long control region (LCR) and the E6 
and E7 genes, whose sequences overlap partially. The E6-1 amplicon (645 bp) is generated first by direct PCR with the LCRS/E7AS primer pair and then 
the E6-2 (237 bp) amplicon is generated by nested PCR with the pU1M/pU2R primer pair. The scale in the lower part of the figure indicates the posi-
tions of LCR, the E6 and E7 oncogenes and the E6-1 and E6-2 amplicon sequences on the HPV16 genome. (B) The E6-645 insert sequence corresponds 
to the cloned E6-1 amplicon, spans nucleotides 26-671 (645 bp) of the HPV16 genome and is flanked by the LCRS and E7AS primers (white letters on 
black background) at the 5' and 3' ends, respectively; it contains 38% GC and is 99% identical to the E6-HPV16 ORF [10]. The fragment corresponding 
to the E2-237 amplicon (in italics) spans nucleotides 419-656 (237 bp) of the HPV16 genome and is flanked by the pU1M and pU2R primers (white 
italics on black background), respectively; its sequence contains 41% GC and is identical to the corresponding ORF sequence of the E6-HPV16 onco-
gene. The three gray italic letters on black background correspond to the overlapping bases of the pU2R and E7AS primers.






LCRS E7AS E6-1    645 bp  
655 409




26 AAGGGCGTAA CCGAAATCGG TTGAACCGAA ACCGGTTAGT ATAAAAGCAG ACATTTTATG
 86 CACCAAAAGA GAACTGCAAT TTTCAGGACC CACAGGAGCG ACCCAGAAAG TTACCACAGT 
146 TATGCACAGA GCTGCAAACA ACTATACATG ATATAATATT AGAATGTGTG TACTGCAAGC 
206 AACAGTTACT GCGACGTGAG GTATATGACT TTGCTTTTCG GGATTTATGC ATAGTATATA
B
206 AACAGTTACT GCGACGTGAG GTATATGACT TTGCTTTTCG GGATTTATGC ATAGTATATA
266 GAGATGGGAA TCCATATGCT GTATGTGATA AATGTTTAAA GTTTTATTCT AAAATTAGTG 
326 AGTATAGACA TTATTGTTAT AGTTTGTATG GAACAACATT AGAACAGCAA TACAACAAAC 
386 CGTTGTGTGA TTTGTTAATT AGGTGTATTA ACTGTCAAAA GC CCACTGTGT CCTGAAGAAC
446 AAGCAAAGAC ATCTGGACAA AAAGCAAAGA TTCCATAATA TAAGGGGTCG GTGGACCGGT
506 GATGTATGTC TTGTTGCAGA TCATCAAGAA CACGTAGAGA AACCCAGCTG TAATCATGCT
566 ATGGAGATAC ACCTACATTG G CATGAATATA A TGTTAGATTT T GCAACCAGAG G ACAACTGATC 566 ATGGAGATAC ACCTACATTG CATGAATATA TGTTAGATTT GCAACCAGAG ACAACTGATC
626 CTACTGTTAT GAGCAATTAA ATGACAGCTC AGAGGAGGAG GATGA
Table 2: Oligonucleotide primers
Pair Primer Sequence (5'T3') Amplicon
1 LCRS (Forward) AAGGGAGTAACCGAAAACGGT E6-1 (645 bp)
E7AS (Reverse) TCATCCTCCTCCTCTGAG
2 pU1M (Forward) TGTCAAAAACCGTTGTGTCC E6-2 (237 bp)
pU2R (Reverse) GAGCTGTCGCTTAATTGCTCHernández-Arteaga and López-Revilla Infectious Agents and Cancer 2010, 5:9
http://www.infectagentscancer.com/content/5/1/9
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the sensitivity and reliability of our nested qPCR method,
since preamplified mixtures containing 50 ng of SiHa
DNA generated Ct values corresponding to one copy of
the E6-HPV16 oncogene per human diploid genome.
T h e  n e s t e d  q P C R  m e t h o d  m a y  a l s o  b e  u s e d  i n  t h e
future to quantify viral load as well as viral and cellular
transcripts with high sensitivity and reliability.
Conclusions
Our method, based on conventional PCR preamplifica-
tion for 15 cycles increased 10,750 times the sensitivity of
nested qPCR for quantitation of the E6 oncogene, and
confirmed that the SiHa cell line contains only one E6-
HPV16 copy per cell.
Methods
Amplification conditions
E-645, the pHV101 insert sequence spanning the E6-
HPV16 open reading frame (ORF), was used as the initial
template to generate the E6-1 (645 bp) amplicon through
conventional direct PCR and then the E6-2 (237 bp)
amplicon through conventional nested PCR (Fig. 3) [10].
E6-1 and E6-2 amplification was maximized in 50 μL
conventional PCR mixtures containing 2.5 × 106 pHV101
copies under the following conditions: 3 mM MgCl2, 0.05
mM of each deoxynucleoside triphosphate (dNTP), 0.15
μM of each of the forward and reverse primers (Table 2),
30 U/ml Taq  polymerase (Invitrogen), and annealing
temperature of 57°C.
PCR products were analyzed by electrophoresis in
sodium borate-1.5% agarose gels [12] for 2 h at 90 V, fol-
lowed by ethidium bromide staining; they were visualized
by ultraviolet light transillumination and their digital
images recorded in a ChemiDoc EQ photodocumenter
(BioRad, Hercules, CA) using the Quantity One (BioRad)
software.
Preamplification and calibration of nested qPCR
Calculation of the number of E6-HPV16 copies is based
on the size of pHV101 (3,645 bp) and the average molecu-
lar weight of a deoxynucleotide pair (650 Da). We esti-
Figure 4 Complete and minimum E6-1 preamplification mixtures used to perform E6-2 nested qPCR amplification. (A) Complete preampli-
fication series. Successive stages: 1) preparation of E6-1 preamplification mixture containing; 2) "preamplification" by conventional PCR; 3) E6-2 ampli-
fication in "nested" qPCR mixtures containing EvaGreen and 1/50 volume of the E6-1 preamplified mixture. Tubes 1, a, b, c and d: positive control 
preamplification mixtures with serial logarithmic dilutions of pHV101 in the range of 2.5 × 106-2.5 × 102 molecules per tube. Tube 2: Blank preamplifi-
cation (without DNA). Tube 3: Problem preamplification (50 ng of SiHa DNA). Tubes 4 and 5: Negative preamplification controls (50 ng "carrier" normal 
human blood DNA). Asterisks indicate preamplified mixtures. (B) Minimum preamplification series. Successive stages: 1) preparation of E6-1 pream-
plification mixture including only the positive control ("calibration") with the highest pHV101 content; 2a) E6-1 "preamplification" by conventional PCR; 
2b) serial logarithmic dilutions of the preamplified calibration mixture; 3) amplification of E6-2 in nested qPCR mixtures containing EvaGreen, the E6-
2 primers and 1/50 volume of E6-1 preamplified mixtures. Tube 1: Positive control amplification mixture with 2.5 × 106 pHV101 molecules. Tube 2: 
Blank preamplification mixture (without DNA). Tube 3: Problem preamplification mixture (50 ng of SiHa DNA). Tubes 4 and 5: Negative preamplifica-
tion controls (50 ng "carrier" normal human blood DNA). Tubes a, b, c, and d: serial logarithmic dilutions from the preamplified positive control mixture 
used to prepare nested qPCR mixtures equivalent to those preamplified with 2.5 × 105-2.5 × 102 pHV101 molecules. Asterisks of numbered tubes in-
dicate preamplified mixtures.Hernández-Arteaga and López-Revilla Infectious Agents and Cancer 2010,
5:9
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mated that 1 ng of pHV101 contains 2.5 × 108 molecules
with the formula of Staroscik [13]: number of copies =
((amount in ng) * 6.022 × 1023))/((length in bp) * 109 *
650).
The E6-1 positive control mixtures required to generate
the family type curves contained the LCRS/E7AS primer
pair, 50 ng of "carrier" normal human DNA and serial log-
arithmic dilutions of pHV101; they were preamplified for
15 cycles (denaturation at 94°C for 15 sec, annealing at
57°C for 1 min and extension at 72°C for 1 min). Problem
preamplification mixtures contained 50 ng of SiHa cell
DNA. Negative controls were a blank (i.e., without DNA)
and another one with 50 ng of carrier normal human
blood DNA.
Positive control preamplification mixtures were pre-
pared either a) as five "complete" PCR mixtures contain-
ing serial logarithmic dilutions of pHV101 to attain 2.5 ×
106-2.5 × 102 pHV101 copies/mixture (Fig. 4A), or b) as a
single "minimum" PCR mixture containing 2.5 × 106
pHV101 copies (Fig. 4B); 1/50 volumes from both types
of mixtures were added to prepare nested qPCR amplifi-
cation mixtures.
qPCR mixtures optimized to amplify E6-2 with the
pU1M/pU2R primer pair in the presence of EvaGreen
(Biotium, Hayward, CA) were incubated with the same
thermocycler program. To control nested amplification
and to determine the number of E6 copies in problem
samples, additional mixtures containing 1/50 volume of
preamplified positive, negative and problem mixtures
were prepared; in these experiments an additional nega-
tive control mixture was used which contained preampli-
fied SiHa DNA and the forward (pU1M) but not the
reverse (pU1R) primer (Fig. 4).
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